SCHEMBL14678655

SCHEMBL14678655

CCCCC(F)(F)C[C@H](NBr)C(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ ZDHHC7 Q9NXF8 1/20 0.39
▸ PDF Q9HBH1 1/20 0.33
▸ TAS1R3 Q7RTX0 3/20 0.33
▸ TAS1R1 Q7RTX1 3/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ USP2 O75604 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ CES2 O00748 2/20 0.31
▸ BIRC2 Q13490 2/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CTSB P07858 1/20 0.31
▸ CTSS P25774 1/20 0.31
▸ CTSK P43235 1/20 0.31
▸ EPHX1 P07099 1/20 0.30
▸ FAAH O00519 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14678629 0.90 CTSB (0.36) CA1CA2ZDHHC7CTSBCTSS
SCHEMBL12508153 0.83 CA1 (0.34) CA1CA2ZDHHC7
SCHEMBL14678650 0.79 NOS3 (0.34) CA1CA2TAS1R3TAS1R1BIRC2
SCHEMBL3210314 0.78 CA1 (0.43) CA1CA2ZDHHC7PDFUSP2
SCHEMBL3210327 0.78 CA1 (0.43) CA1CA2ZDHHC7PDFUSP2
Bromide SCHEMBL1200280 0.76 CA1 (0.42) CA1CA2ZDHHC7PDFUSP2
Bromide SCHEMBL1200279 0.76 CA1 (0.42) CA1CA2ZDHHC7PDFUSP2
SCHEMBL8005182 0.76 CTSB (0.37) CA1CA2ZDHHC7PDFTAS1R3
SCHEMBL8011302 0.75 SIRT2 (0.53) ALDH1A1CTSBCTSSCTSK
SCHEMBL12508104 0.71 TSHR (0.47) CA2ALDH1A1LMNACYP2C9CTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140221478-A1 DI-FLUORO CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY, INC. (US) 2014-08-07 — — US disclosed
US-8748649-B2 Di-fluoro containing compounds as cysteine protease inhibitors VIROBAY, INC. (US) 2014-06-10 — — US disclosed
US-20140018421-A1 DI-FLUORO CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY, INC. (US) 2014-01-16 — — US disclosed
US-8367732-B2 Di-fluoro containing compounds as cysteine protease inhibitors VIROBAY, INC. (US) 2013-02-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221478-A1 DI-FLUORO CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS CTSF, CTSZ, CTSS CA1 634/4885CA2 885/4885ZDHHC7 626/4885
US-20140018421-A1 DI-FLUORO CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS CTSF, CTSZ, CTSS CA1 634/4885CA2 885/4885ZDHHC7 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback